Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy for Initial Peri-implantitis
NCT02848482Phase 3Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- May 2017
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Change of percentage of bleeding on probing sites at 12 months. Started May 2017; status: completed.
Beyond the preview
Go deeper on NCT02848482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02848482.